Evaluating human health risk assessment tools for contaminated soil: a comparative review

by | feb 4, 2026

Environ Sci Pollut Res Int. 2026 Feb 4. doi: 10.1007/s11356-026-37411-w. Online ahead of print.

ABSTRACT

At the European Union level, approximately 60-70% of soil is in unhealthy or degraded conditions. One of the soil threats is the legacy of industrial pollution, as historic industrial pollutants discharged into the ground continue to pose risks to both the environment and human health. As part of the legislative measures adopted in the late 90 s, Human Health Risk Assessment (HHRA) was introduced as a standardized method for evaluating risks associated with contaminated sites. To support the quantification of these risks, various software tool models were developed. This study reviews 12 HHRA tools for contaminated sites developed across different countries. First, an overview of national legislative frameworks concerning contaminated sites, with a particular focus on the use of HHRA as a decision-making tool, is provided. Subsequently, the study compares and discusses the methodologies adopted by each tool, the exposure pathways and receptors considered, the integrated contaminant databases, and additional features provided by the models. The comparison highlights the diversity of functionalities offered by the different tools, reflecting a lack of harmonization among national regulations regarding contaminated site management. Beyond the need for a harmonized approach at the EU level, potential future developments include the design of more user-friendly interfaces capable of expanding exposure scenarios, updating contaminant lists (including emerging pollutants such as PFAS), integrating uncertainty analysis, incorporating Geographic Information System (GIS)-based visualizations, and integrating artificial intelligence (AI)/machine learning (ML).

PMID:41636942 | DOI:10.1007/s11356-026-37411-w

The Pharmaceutical Industry in 2025: An Analysis of FDA Drug Approvals from the Perspective of Molecules

In 2025, the U.S. Food and Drug Administration (FDA) approved 44 new drugs, reflecting a slight decrease compared to previous years but maintaining the overall trends in pharmaceutical innovation. Biologics accounted for 25% of approvals, including nine monoclonal antibodies (mAbs), two antibody-drug conjugates (ADCs), and one fusion protein, with cancer remaining the primary therapeutic focus. TIDES, comprising three oligonucleotides and one peptide, continued to consolidate their presence in…

Trends of global concerns on groundwater contamination and future directions

Groundwater is a vital freshwater resource but is increasingly threatened by both conventional pollutants and contaminants of emerging concern (CECs). This review synthesizes the evolution of groundwater contamination research using a bibliometric analysis of 38,759 publications from 1991 to 2024. Scientific production rose sharply after 2004, driven by China and India, while Africa and parts of South Asia remain underrepresented despite facing serious groundwater challenges. Thematic mapping…

Fermentum Ligula Bibendum

Adipiscing Ridiculus Purus Ultricies

Donec ullamcorper nulla non metus auctor fringilla. Integer posuere erat a ante venenatis dapibus posuere velit aliquet. Cras justo odio, dapibus ac facilisis in, egestas eget quam. Etiam porta sem malesuada magna mollis euismod.

0
    0
    Je Winkelwagen
    Je winkelwagen is leeg.Terug naar Winkel